Displaying 731 - 740 of 838
15 March 2018
Learn more about ADB's focus and action areas in the field of health and education, particularly in East Asia.
15 March 2018
Learn more about ADB's focus and action areas in the field of health and education, particularly in Southeast Asia.
15 March 2018
Learn more about ADB's focus and action areas in the field of health and education, particularly in Southeast Asia.
15 March 2018
Learn more about ADB's focus and action areas in the field of health and education, particularly in the Pacific.
15 March 2018
Public-Private Partnership (PPP) is seen as an important modality for attracting private investment and efficiency gains in infrastructure. Check out how ADB is supporting PPP.
15 March 2018
Learn more about ADB's focus and action areas in the field of health and education. This presentation gives an overview of both sectors' portfolio and vision.
12 March 2018
Discover how Lao PDR is improving quality of care to achieve better health outcomes.
As countries in the Asia-Pacific region strive to achieve universal health coverage, removing financial barriers to health care is fundamental yet not sufficient. Utilization of health services and the achievement…
21 February 2018
The excise tax on sweetened beverage is a health tax in the Philippines that helps address diabetes and obesity given the high incidence of obesity and fast-growing incidence of diabetes. It is part of a package of the tax reform program for more inclusive growth and a healthy Philippines.
5 February 2018
With increasing Universal Health Coverage, expanding health insurance schemes, and the desire for better disease surveillance comes the need for unique health identification.
Michael Stahl provides an overview of the status of unique identification in the health sector in ADB member countries and…
25 January 2018
There is no room for malaria in Myanmar. Health expert Valerio Reggi shares Myanmar's moves to eliminate the disease.
ADB is helping to strengthen Myanmar's regulatory capacity; ensure effective assessments of medicines; and reduce the risk of substandard and falsified medicines, particularly anti…